phase 1_completion
saveShanghai Institute of Biological Products Co Ltd — SIBPA-13 (Phase I Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Breast Cancer, Head And Neck Squamous Cell Carcinoma (HNSC), Non-Small Cell Lung Cancer, Solid Tumor
Data sources
globaldata
Found something off?
comments(0)
5-min edit window · permanent after that